WHO ICTRP trial
Optimizing propofol dosing for (preterm) newborn infants that need endotracheal…
NL-OMON45172 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON45172 |
|---|---|
| Public title | Optimizing propofol dosing for (preterm) newborn infants that need endotracheal intubation |
| Scientific title | Optimizing propofol dosing for (preterm) newborn infants that need endotracheal intubation - NEOPROP2 |
| Primary sponsor | Erasmus MC, Universitair Medisch Centrum Rotterdam |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | The Netherlands |
| Conditions | sedatie bij verrichting sedation;sedation |
| Interventions | Adapted propofol dose. Starting dose is dependent on effects of previously included patients. Dose is increased in case of insufficient sedation. Intubation is started only after sedation level is adequate (titration with additional… |
| Registration date | Aug 15, 2018 |
| Target size | 160 |
| Secondary IDs | 2013-005572-17 ;20132312;NL47609.078.14 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: